Hyaluronic Acid
Hyaluronic Acid scored 6.8 / 10 (👍 Worth trying) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
Hyaluronic acid is a glycosaminoglycan used orally for skin and joints and topically for hydration. The oral skin signal is real but modest: a meta-analysis by Sun 2022 pooled 4 RCTs (196 adults) and found a small significant hydration gain (SMD +0.40, p=0.007). Knee osteoarthritis pain improves mildly, dry-eye drops work, and safety is excellent.
What is Hyaluronic Acid?
Hyaluronic acid is a glycosaminoglycan your body already makes and stores in skin, joints, eyes, and connective tissue, where its defining trick is binding water, up to roughly a thousand times its own weight. As a supplement it shows up three ways: oral capsules or liquid, topical serums, and lubricating eye drops. It scores 6.83 and lands in the worth-trying tier because the human evidence is consistent in direction but modest in size, while the safety and cost profile is close to ideal. The clearest result comes from Sun 2022, a meta-analysis whose oral hyaluronan arm pooled 4 RCTs and 196 adults and found a small but significant skin-hydration gain. This is a sensible add-on for skin and mild joint goals, not a heavy hitter.
The molecule itself (PubChem CID 7526) is a long polysaccharide chain that holds water and props up the extracellular matrix. Orally, gut bacteria break a fraction into lower molecular weight fragments that get absorbed and may act as matrix substrate and as signals through the CD44 receptor. Note one important boundary: injectable HA dermal fillers and joint viscosupplementation are separate clinical procedures with their own much larger local effects and their own risks. This report scores the oral and topical supplement; the injectables are mentioned only to keep the categories straight. People also pair HA with oral collagen peptides for skin, which is a reasonable stack.
Terminology
Hyaluronic acid carries a few terms that change how you read the evidence, mostly around chemistry and route. The single most decision-relevant one is molecular weight, because it determines absorption and which use case applies. The rest separate the cheap, safe supplement from the clinical injectable procedures that share the same molecule but not the same risk profile.
- Glycosaminoglycan: A long sugar-chain molecule that forms part of connective tissue and holds water; hyaluronic acid is one.
- Hyaluronan: A synonym for hyaluronic acid, often used in research.
- Sodium hyaluronate: The sodium salt of hyaluronic acid, the common supplement and eye-drop form, more water-soluble.
- Molecular weight (kDa): The size of the HA chain. Low molecular weight (roughly 50 to 300 kDa) absorbs orally and penetrates skin; high molecular weight sits on the surface and dominates injectables.
- Extracellular matrix: The structural scaffold around cells that HA helps hydrate and support.
- Stratum corneum: The outermost skin layer whose water content topical HA raises.
- Transepidermal water loss (TEWL): How fast water evaporates through skin; lower means a better barrier.
- CD44: A cell-surface receptor hyaluronic acid binds to, involved in tissue signaling.
- Viscosupplementation: A clinical procedure injecting HA into a joint; a separate intervention from the supplement.
- Dermal filler: An injected HA gel for cosmetic volume; a clinical procedure, not the supplement.
- SMD: Standardized mean difference, a meta-analysis effect-size metric.
- VAS: Visual analog scale, a 0 to 10 self-reported pain measure used in osteoarthritis trials.
- WOMAC: Western Ontario and McMaster osteoarthritis index, a joint pain and function questionnaire.
- GRAS: Generally Recognized As Safe, an FDA food-ingredient safety status.
How do you take Hyaluronic Acid?
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
View 3 routes and 3 protocols
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral capsule or liquid | Low molecular weight sodium hyaluronate (roughly 50-300 kDa) | 80-200 mg/day | 80-300 mg/day |
| Topical serum | 0.1-2% hyaluronic acid in a water-based or emulsion serum | Once or twice daily | Once or twice daily |
| Ophthalmic drops | 0.1-0.4% sodium hyaluronate eye drops | 1 drop, 2-6 times daily as needed | As needed |
Protocols
Skin hydration (oral) Clinical
- Dose
- 120 mg/day
- Frequency
- Once daily
- Duration
- 8-12 weeks minimum
Pairs logically with oral collagen peptides; track corneometry or a fixed photo, not vibes. See /reports/collagen-peptides/.
Knee osteoarthritis (oral) Clinical
- Dose
- 80-200 mg/day
- Frequency
- Once daily
- Duration
- 8 weeks, reassess
Most trials combine HA with glucosamine or chondroitin, so isolate the effect by tracking pain and NSAID use before and after.
Dry eye (topical drops) Clinical
- Dose
- 0.1-0.4% drops
- Frequency
- 2-6 times daily
- Duration
- Ongoing as needed
Symptomatic lubrication; pair with addressing screen time, blink rate, and meibomian gland health.
How this score is calculated →
What are the benefits of Hyaluronic Acid?
Upside contribution: 1.90
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 3.0 | 0.750 | |
| Breadth | 15% | 3.0 | 0.450 | |
| Evidence | 25% | 3.0 | 0.750 | |
| Speed | 10% | 2.5 | 0.250 | |
| Durability | 10% | 2.5 | 0.250 | |
| Bioindividuality | 15% | 3.0 | 0.450 | |
| Total | 2.900 |
Upside Rationale
The upside is broad but shallow: hyaluronic acid touches skin, joints, and eyes with real, replicated effects, yet each effect is modest and the strongest results come from topical and ophthalmic routes rather than the oral capsule. The best human evidence is Sun 2022, whose oral hyaluronan arm pooled 4 RCTs and 196 adults for a significant skin-hydration gain. The key boundary condition across every use case is molecular weight and formulation: low molecular weight forms absorb and penetrate, high molecular weight forms hold surface water or fill joints. Get the form wrong and the effect largely disappears, which is the most common reason a given HA product underwhelms.
Efficacy (3.0/5.0): Real but modest is the honest read. Sun 2022 found the oral hyaluronan arm (4 RCTs, 196 adults) produced a small significant skin-hydration effect at SMD +0.40 (p=0.007), squarely in the small-to-moderate band. Hsu 2021 showed 120 mg/day for 12 weeks improved wrinkle scores, stratum corneum water content, and elasticity in 40 adults. For joints, Cicero 2020 cut VAS pain and weekly NSAID use versus placebo at 200 mg/day. These are useful, measurable changes, not transformative ones, which is exactly why the dimension sits at the midpoint rather than higher.
Breadth of Benefits (3.0/5.0): Hyaluronic acid reaches several systems with at least one named endpoint each. Skin: hydration and wrinkle depth per Hsu 2021. Joints: osteoarthritis pain and function per de Carvalho 2024, where 9 of 11 studies improved. Eyes: tear production and tear-film stability via drops per Yang 2021. The boundary is that breadth comes from HA being a structural body molecule, so benefits cluster in water-rich, matrix-rich tissues and do not extend convincingly to metabolic, cardiovascular, or cognitive endpoints, where evidence is absent.
Evidence Quality (3.0/5.0): The base is solid but unspectacular. Multiple meta-analyses and RCTs exist across skin, joints, and dry eye, including Sun 2022, Yang 2021 (19 RCTs, 2,078 eyes), and the de Carvalho 2024 systematic review. The limits keep it at 3.0: trials are short and small, 8 of 10 knee studies combined HA with glucosamine or chondroitin so the isolated oral effect is hard to size, and several skin trials are industry-adjacent. There is no Cochrane review elevating it. Consistent direction across independent groups earns the midpoint; the precision gaps stop it from going higher.
Speed of Onset (2.5/5.0): Route decides everything. Topical serums hydrate within minutes to hours, the fastest and most visible effect. Dry-eye drops give relief within days. Oral skin endpoints in Hsu 2021 took 8 to 12 weeks, and knee osteoarthritis pain in Cicero 2020 improved over 4 to 8 weeks. Because the supplement use cases people care most about (oral skin and joint) are slow, the dimension lands below the midpoint despite the instant topical effect.
Durability (2.5/5.0): Benefits are use-dependent. Topical hydration fades within a day or two of stopping, oral skin and joint gains regress over weeks once supplementation ends, and dry-eye drops are purely symptomatic. Hyaluronic acid does not appear to remodel tissue in a way that persists after washout, so continued use is required to hold any effect. That puts durability below the midpoint, consistent with a hydration-and-support agent rather than a structural one.
Bioindividuality Upside (3.0/5.0): Responders are reasonably predictable. People with dry skin, visible photoaging, symptomatic knee osteoarthritis, or dry-eye disease have the most to gain, because they start furthest from baseline. Weak responders are those with already-hydrated skin or no joint complaints. The biggest controllable predictor is product choice: low molecular weight oral forms and appropriately formulated topicals respond, while unspecified-weight products are a coin flip. Gut microbiome differences may also shift how much oral HA is converted to absorbable fragments, adding individual variance.
What are the risks & downsides of Hyaluronic Acid?
Downside contribution: 0.44 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety | 30% | 1.5 | 0.450 | |
| Side effects | 15% | 1.5 | 0.225 | |
| Cost | 5% | 2.0 | 0.100 | |
| Effort | 5% | 1.5 | 0.075 | |
| Opportunity | 5% | 2.0 | 0.100 | |
| Dependency | 15% | 1.0 | 0.150 | |
| Reversibility | 25% | 1.0 | 0.250 | |
| Total | 1.350 | |||
| Harm subtotal × 1.4 | 1.505 | |||
| Opportunity subtotal × 1.0 | 0.275 | |||
| Combined downside | 1.780 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 0.440 |
Downside Rationale
The downside is genuinely small, which is most of why this scores in worth-trying despite modest efficacy. There is no intrinsic catastrophic risk, no dependency, and clean reversibility. The dominant real-world risks people associate with hyaluronic acid (injection reactions, rare filler vascular events) belong to the clinical injectable procedures, not the oral capsule or topical serum scored here, so per the rule to score the intervention as used they sit in the verdict caveat rather than the safety dimension. The only practical costs are a few dollars a month and the opportunity cost of choosing HA over a better-evidenced option for a specific goal.
Safety Risk (1.5/5.0): Oral and topical hyaluronic acid have an excellent safety profile with no intrinsic life-threatening or disabling mechanism, so the catastrophic floor does not apply. Oral HA ingredients hold FDA GRAS or notified status, and HA is an endogenous human molecule, which keeps systemic risk minimal. The serious adverse events that show up in searches (injection-site infection, granuloma, rare vascular occlusion from fillers) are properties of the injectable procedures regulated as medical devices, not the supplement; they are surfaced in the verdict, not scored here. For the oral and topical product as actually used, safety is genuinely benign, earning a low 1.5.
Side Effect Profile (1.5/5.0): Side effects are rare and mild. Oral use occasionally causes minor digestive complaints; topical use can cause transient irritation or, in very dry air, a tight feeling if HA is not sealed with a moisturizer. Trials including Hsu 2021 and Cicero 2020 reported good tolerability with no notable adverse-event signal versus placebo. There is no form-dependent toxicity at supplement doses, which keeps this dimension near the floor.
Financial Cost (2.0/5.0): Oral hyaluronic acid runs about $15 to $40 per month at 120 to 200 mg/day, and topical serums range $10 to $60. Generic and branded forms perform similarly when dose and molecular weight match, so there is little reason to overpay. The cost is low in absolute terms but not free, and stacking HA with collagen and other skin or joint products adds up, which is why it sits slightly above the floor.
Time/Effort Burden (1.5/5.0): Effort is trivial. A once-daily capsule, a serum applied during an existing skincare routine, or drops as needed. No cycling, timing tricks, or special handling required. The only minor effort is reading the label to confirm molecular weight, which most people skip.
Opportunity Cost (2.0/5.0): The main opportunity cost is choosing HA over a better-evidenced option for a specific goal. For skin hydration, oral collagen peptides carry a larger effect size in the same Sun 2022 meta-analysis, so HA is a complement rather than the lead. For knee osteoarthritis, exercise, weight management, and proven analgesics outrank a modest supplement. HA stacks cleanly and crowds out nothing physiologically, but it can crowd out attention and budget if treated as a primary therapy, which keeps this just above the floor.
Dependency/Withdrawal (1.0/5.0): None. Hyaluronic acid produces no tolerance, craving, or withdrawal syndrome. Stopping simply lets effects fade as the supplemented or topical HA clears, with no adaptation to unwind. This is a clean floor score.
Reversibility (1.0/5.0): Fully reversible. There are no permanent changes from oral or topical HA; benefits regress and the body returns to baseline within days to weeks of stopping. No taper is needed and nothing accumulates, so reversibility scores at the floor for the supplement and serum (injectable fillers, which can persist for months, are a separate procedure).
Is Hyaluronic Acid worth it?
Hyaluronic acid is a 6.83 out of 10, worth-trying pick for people targeting skin hydration, mild joint comfort, or dry eye who want a cheap, near-foolproof, very safe add-on and are willing to track one endpoint rather than expect a dramatic effect. The evidence-risk balance justifies the tier cleanly: Sun 2022 and Hsu 2021 show real oral skin benefit, de Carvalho 2024 shows mild joint benefit, and dry-eye drops are a confirmed mainstream lubricant, all against an essentially benign safety profile. It is not a strong recommend because the oral effect sizes stay small and molecular weight drives much of the result. Buy it as a complement, not a centerpiece, and choose a low molecular weight form.
✅ Best for: Adults with dry skin or visible photoaging who want a low-friction hydration add-on and will use a topical serum plus an optional 120 mg/day oral capsule. People with mild-to-moderate knee osteoarthritis who already exercise and manage weight, and want an adjunct that may trim NSAID use per Cicero 2020. Anyone with dry-eye symptoms who needs a mainstream lubricating drop. Skin-focused stackers who already take collagen peptides and want a complementary hydration mechanism. Cost-sensitive readers who want a safe entry supplement with a real, if modest, instrument-measurable effect.
❌ Avoid if: You expect a dramatic anti-aging or cartilage-regrowing result, because the oral effect sizes are small. You want the joint or facial-volume benefit of an injection, which is a separate clinical procedure: HA dermal fillers and viscosupplementation carry injection-site, infection, and rare vascular risks and require a qualified clinician, so do not conflate them with the supplement. You react to a specific product, which usually means an excipient allergy rather than HA itself. Sourcing caveat: pick a product that states its molecular weight and dose, since unlabeled forms are the main reason HA underdelivers, and pregnant or breastfeeding people should default to topical use and ask a clinician before oral supplementation.
What is Hyaluronic Acid best for?
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Skin / Beauty: 6.5/10
Score: 6.5/10Skin is hyaluronic acid's strongest case at 6.5/10. Sun 2022 pooled 4 oral RCTs (196 adults) and found a small but significant hydration gain (SMD +0.40, p=0.007), and Hsu 2021 showed 120 mg/day for 12 weeks improved wrinkle scores, stratum corneum water content, and elasticity in 40 adults. Topically, Bravo 2022 documents immediate, reliable surface hydration. The honest framing: the effect is real and visible to instruments, but modest and dependent on molecular weight and formulation, not a structural rebuild of aged skin.
Bone / Joint Health: 5.5/10
Score: 5.5/10Joint health rates 5.5/10. de Carvalho 2024 reviewed 11 studies (mostly knee osteoarthritis RCTs) and found 9 of 11 showed pain or function improvement, and Cicero 2020 showed 200 mg/day of oral sodium hyaluronate cut VAS pain and weekly NSAID use versus placebo over 8 weeks in 60 patients. The limitation is real: 8 of 10 knee trials combined HA with glucosamine or chondroitin, so the isolated oral-HA effect is hard to size. Mild, adjunctive symptom relief is the defensible claim, not cartilage regrowth.
Eye / Vision Health: 6.0/10
Score: 6.0/10Dry-eye relief earns 6.0/10, driven by the topical drop, not the oral capsule. Yang 2021 pooled 19 RCTs (2,078 eyes) and found hyaluronic acid eye drops significantly improved tear production versus non-HA drops (Schirmer SMD +0.18; +0.27 versus saline) and helped tear-film stability. HA drops are a mainstream lubricant for dry-eye disease. This subrating is for the ophthalmic route; oral HA has no meaningful direct vision evidence, so do not extrapolate the capsule to your eyes.
| Use Case | Score | Summary |
|---|---|---|
| ○ Wound Healing Primary | 4.5 | Wound and tissue repair sits at 4.5/10. HA is a genuine extracellular-matrix component and topical and dressing forms are used clinically for wounds, but high-quality oral-supplement outcome data for everyday wound healing is thin. Mechanistically plausible and used in dressings; not a reason to take the oral capsule. |
| ○ Anti-Inflammatory | 3.5 | Anti-inflammatory effects rate 3.5/10. Any benefit is indirect via joint and tissue support rather than systemic inflammatory-marker suppression. HA is not a reliable way to move CRP or IL-6, and trials do not support a strong systemic anti-inflammatory claim. |
| ○ Recovery / Repair | 3.5 | General recovery rates 3.5/10 by extension of the joint and matrix-support mechanism, but dedicated recovery-endpoint trials are lacking. Reasonable as an adjunct, not a primary recovery tool. |
| ○ Chronic Pain Management | 3.5 | Indirect via osteoarthritis joint comfort per de Carvalho 2024; not a general analgesic and weak outside joint pain. |
| ○ Flexibility / Mobility | 3.5 | Joint comfort may translate to better mobility in osteoarthritis, but this is downstream of the modest joint effect, not a direct mobility result. |
| ○ Hair / Nail Health | 3.0 | Hair and nails rate 3.0/10. Scalp and skin hydration overlap may help appearance indirectly, but there is no strong hair-growth or nail-strength endpoint evidence for oral or topical HA. |
| ○ Healthspan | 3.0 | Healthspan rates 3.0/10. HA supports tissues that decline with age, and dietary or supplemental HA is benign, but there is no longevity or healthspan outcome data; the score reflects plausible support, not demonstrated benefit. |
| ○ Gut Health / Microbiome | 3.0 | Oral HA is partly metabolized by gut bacteria, and some preclinical gut-barrier data exists, but human gut-outcome evidence is limited. |
| ○ Injury Recovery | 3.0 | Matrix-support logic and clinical joint-injection use are relevant, but oral-supplement injury-recovery endpoints are limited. |
Frequently Asked Questions
What does hyaluronic acid actually do in the body?
Hyaluronic acid is a glycosaminoglycan your body already makes, concentrated in skin, joints, and eyes, where it binds large volumes of water and supports the extracellular matrix. Topically it hydrates the stratum corneum and lowers water loss; in joints it lubricates and cushions; it also signals through the CD44 receptor. Taken orally, a fraction is broken into lower molecular weight fragments that are absorbed and may act as matrix substrate, which is the leading explanation for the small oral skin and joint effects seen in trials.
How much oral hyaluronic acid should I take, and when?
Most oral skin trials use 120 mg/day, and oral knee osteoarthritis trials use roughly 80-200 mg/day, taken once daily. Hsu 2021 used 120 mg/day for 12 weeks, and Cicero 2020 used 200 mg/day for joints. Choose a low molecular weight form (roughly 50-300 kDa) because it absorbs better. Give it 8 to 12 weeks before judging, and track one endpoint such as skin dryness or morning joint stiffness.
What does the human evidence actually show for hyaluronic acid?
The evidence is consistent in direction but modest in size. Sun 2022 pooled 4 oral RCTs (196 adults) and found a small significant skin-hydration gain (SMD +0.40, p=0.007). de Carvalho 2024 found 9 of 11 osteoarthritis studies showed pain or function improvement, though most combined HA with other agents. Yang 2021 confirmed eye-drop benefit across 19 RCTs. Real, useful, but small effects, not dramatic ones.
Is hyaluronic acid safe to take long term?
Oral and topical hyaluronic acid have an excellent safety record with no intrinsic catastrophic risk, and oral ingredients hold FDA GRAS or notified status. Side effects are rare and mild, mostly minor digestive complaints orally or occasional irritation topically. The notable risks people associate with HA belong to the injectable procedures, not the supplement or serum: dermal fillers and joint viscosupplementation carry injection-site reactions and, rarely, vascular events. Those are clinical procedures, scored separately from this supplement.
Who should avoid hyaluronic acid?
Very few people need to avoid oral or topical hyaluronic acid. Stop if you react to a specific product, which usually points to an excipient rather than HA itself. People considering dermal fillers or joint injections should use a qualified clinician, since vascular and infection risks live with the injection, not the molecule. Pregnant or breastfeeding people should default to topical use and ask a clinician before oral supplementation, since dedicated safety data in pregnancy is limited even though risk appears low.
Oral capsules versus topical serums versus injections: which hyaluronic acid is right?
Match the form to the goal. Topical serums give immediate, reliable surface hydration per Bravo 2022 and are the cheapest visible win. Oral capsules at 120 mg/day produce small whole-skin and joint effects over weeks. Eye drops are the right tool for dry eye. Dermal fillers and joint viscosupplementation are clinical procedures with the largest local effect and the only meaningful risks, and they are scored separately. For most readers, a topical serum plus an optional oral capsule covers the supplement case.
How fast does hyaluronic acid work?
Speed depends entirely on the route. Topical serums hydrate within minutes to hours, which is why skin looks plumper the same day. Oral skin endpoints in trials like Hsu 2021 take 8 to 12 weeks. Knee osteoarthritis pain in trials such as Cicero 2020 improves over 4 to 8 weeks. Dry-eye relief from drops is felt within days. Plan to evaluate oral use after at least two months.
Does molecular weight of hyaluronic acid matter?
Molecular weight is one of the few HA variables that clearly changes the result. Low molecular weight HA (roughly 50-300 kDa) is absorbed more readily orally and is what most skin trials use, while high molecular weight HA dominates injectable joint products and fillers. Low molecular weight also penetrates skin better topically, whereas high molecular weight sits on the surface and holds water. A product that does not state its molecular weight is a weaker bet, since this single spec drives much of the difference between brands.
What could change Hyaluronic Acid's score?
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
The most plausible upward move is a large, well-designed oral RCT using a defined low molecular weight form that shows a clinically visible (not just instrument-detectable) skin or joint effect, which would lift Efficacy and Evidence together. The most plausible downward move is a rigorous trial isolating oral HA from glucosamine and chondroitin in osteoarthritis and finding the joint benefit was carried by the co-ingredients. Topical and dry-eye evidence is already solid, so those routes are unlikely to move the supplement score much. Confidence, currently moderate, would rise to high only with larger, longer, independently funded oral trials.
| Scenario | Dimension shifts | New Score |
|---|---|---|
| Large independent oral RCT shows clinically visible skin benefit | Efficacy 3.0 to 3.5, Evidence 3.0 to 3.5 | 7.4 / 10 💪 Strong recommend |
| Trial isolating oral HA in osteoarthritis confirms standalone joint benefit | Efficacy 3.0 to 3.5, Breadth 3.0 to 3.5 | 7.3 / 10 💪 Strong recommend |
| Isolation trial shows oral joint benefit was driven by co-ingredients | Efficacy 3.0 to 2.5, Breadth 3.0 to 2.5 | 6.3 / 10 👍 Worth trying |
| Long-term durability data shows effects persist after stopping | Durability 2.5 to 3.5 | 7.0 / 10 💪 Strong recommend |
| New meta-analysis downgrades oral skin effect to non-significant | Efficacy 3.0 to 2.5, Evidence 3.0 to 2.5 | 6.0 / 10 👍 Worth trying |
| Better low molecular weight delivery raises absorption and effect size | Efficacy 3.0 to 3.5, Speed 2.5 to 3.0, Bioindividuality 3.0 to 3.5 | 7.6 / 10 💪 Strong recommend |
Key Evidence Sources
- Sun H et al. 2022 - Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Frontiers in Nutrition. Meta-analysis; hyaluronan arm pooled 4 RCTs and 196 participants and found a small significant skin-hydration effect (SMD +0.40, p=0.007).
- Hsu T-F et al. 2021 - Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study, Nutrients. 12-week RCT; 40 adults; 120 mg/day improved wrinkle scores, stratum corneum water content, transepidermal water loss, and elasticity versus placebo.
- de Carvalho ALA et al. 2024 - Oral Hyaluronic Acid in Osteoarthritis and Low Back Pain: A Systematic Review, Mediterranean Journal of Rheumatology. Systematic review of 11 studies (mostly knee osteoarthritis RCTs); 9 of 11 showed pain or function improvement; 8 of 10 knee trials combined HA with other agents.
- Cicero AFG et al. 2020 - Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial, Diseases. RCT; 60 patients; 200 mg/day for 8 weeks significantly reduced VAS pain and weekly NSAID use versus placebo.
- Yang Y-J et al. 2021 - A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome, International Journal of Environmental Research and Public Health. Meta-analysis of 19 RCTs (2,078 eyes); HA eye drops improved tear production versus non-HA drops (Schirmer SMD +0.18; +0.27 versus saline).
- Bravo B et al. 2022 - Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence, Dermatologic Therapy. Review; topical HA reliably increases stratum corneum hydration and lowers transepidermal water loss in short trials; extracellular-matrix HA declines with age.
- PubChem - Hyaluronic acid (CID 7526), compound record. Chemical identity reference for the glycosaminoglycan hyaluronic acid; basis for entity disambiguation in this 2026 review.
- Wikidata - hyaluronic acid (Q337231), naturally occurring polysaccharide and glycosaminoglycan. Canonical entity record used for JSON-LD sameAs linking; confirms glycosaminoglycan classification cited in this 2026 review.
- FDA - GRAS Notice inventory, hyaluronic acid / sodium hyaluronate notified ingredients. Regulatory context; oral hyaluronic acid ingredients hold GRAS or notified status, supporting the over-the-counter dietary supplement classification in this 2026 review.
- FDA - Dermal Fillers (Soft Tissue Fillers) device and safety information. Authority context; HA dermal fillers are regulated as medical devices with injection-specific risks, distinct from the oral or topical supplement reviewed in this 2026 study.
What does the evidence say about Hyaluronic Acid?
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Medium
Citations: Sun 2022, Hsu 2021, Cicero 2020, Yang 2021, Bravo 2022
Traditional Medicine Systems
Confidence: Low
Citations: Bravo 2022
Holistic Evidence for Hyaluronic Acid
The modern and biological lenses agree: hyaluronic acid is a native, well-tolerated molecule whose supplemented and topical effects are real but modest, with route and molecular weight deciding most of the result.
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Pulse Dimensions to Watch
- Body During | Expected Up | Primary
- Body Baseline (pre-protocol) | Secondary
Subjective Signals (Daily Voice Card)
- Skin hydration and tightness Scale 1-5 | During | Expected Up
- Knee or joint stiffness on waking Scale 1-5 | During | Expected Down
Red Flags: Stop and Consult
- Localized swelling, vision change, or skin blanching after a dermal-filler or viscosupplementation injection: seek urgent care; these are injectable-procedure risks, not supplement risks
- New rash or hives after an oral or topical product: stop and rule out an excipient allergy
Other interventions for Skin & Beauty
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–2.9, Caution 3.0–4.4, Neutral 4.5–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–8.7, Top-tier 8.8–10.0.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.900 − 0.440 = 1.460
Formula v2.0 maps EV = 0 to score 5.0. Above neutral, EV = +4.00 reaches 10.0; below neutral, EV = −5.36 reaches 0.0. Both sides use the full 5-point half-scale.
Score = 5 + (1.460 / 4.00) × 5 = 6.8 / 10
